Invention Grant
US08772481B2 Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof
有权
氮杂和二氮杂 - 酞嗪化合物作为P38映射激酶调节剂及其使用方法
- Patent Title: Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof
- Patent Title (中): 氮杂和二氮杂 - 酞嗪化合物作为P38映射激酶调节剂及其使用方法
-
Application No.: US13123885Application Date: 2009-10-07
-
Publication No.: US08772481B2Publication Date: 2014-07-08
- Inventor: Andrew Tasker , Liping H. Pettus , Ryan Wurz
- Applicant: Andrew Tasker , Liping H. Pettus , Ryan Wurz
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent G. Prabhakar Reddy
- International Application: PCT/US2009/059883 WO 20091007
- International Announcement: WO2010/042646 WO 20100415
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; A61K31/50 ; C07D413/14 ; C07D487/04
Abstract:
The present invention comprises a new class of compounds useful for the prophylaxis and treatments of protein kinase mediated diseases, including inflammation and related conditions.
Public/Granted literature
- US20120108587A1 Aza- and Diaza-Phthalazine Compounds as P38 Map Kinase Modulators and Methods of Use Thereof Public/Granted day:2012-05-03
Information query
IPC分类:
